Financhill
Sell
37

WBA Quote, Financials, Valuation and Earnings

Last price:
$10.51
Seasonality move :
0.25%
Day range:
$10.10 - $10.97
52-week range:
$8.08 - $22.05
Dividend yield:
9.27%
P/E ratio:
--
P/S ratio:
0.06x
P/B ratio:
0.94x
Volume:
21.9M
Avg. volume:
28M
1-year change:
-50.91%
Market cap:
$9.3B
Revenue:
$147.7B
EPS (TTM):
-$10.24

Analysts' Opinion

  • Consensus Rating
    Walgreens Boots Alliance has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 11 Hold ratings, and 2 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $12.35, Walgreens Boots Alliance has an estimated upside of 14.43% from its current price of $10.79.
  • Price Target Downside
    According to analysts, the lowest downside price target is $7.00 representing 35.13% downside risk from its current price of $10.79.

Fair Value

  • According to the consensus of 16 analysts, Walgreens Boots Alliance has 14.43% upside to fair value with a price target of $12.35 per share.

WBA vs. S&P 500

  • Over the past 5 trading days, Walgreens Boots Alliance has overperformed the S&P 500 by 14.72% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Walgreens Boots Alliance does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Walgreens Boots Alliance has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Walgreens Boots Alliance reported revenues of $39.5B.

Earnings Growth

  • Walgreens Boots Alliance has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Walgreens Boots Alliance reported earnings per share of -$0.31.
Enterprise value:
17.5B
EV / Invested capital:
0.91x
Price / LTM sales:
0.06x
EV / EBIT:
--
EV / Revenue:
0.12x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-50.53x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$26.5B
Return On Assets:
-10.4%
Net Income Margin (TTM):
-5.87%
Return On Equity:
-53.86%
Return On Invested Capital:
-34.71%
Operating Margin:
-0.6%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-11-30 2023-11-30 2024-11-30 2023-11-30 2024-11-30
Income Statement
Revenue $132.2B $142.4B $150.4B $36.7B $39.5B
Gross Profit $27.6B $26.9B $26.5B $6.8B $6.8B
Operating Income -$6.4B -$1B -$1.7B -$80M -$236M
EBITDA -$2.7B $2.4B -$11.4B $357M $209M
Diluted EPS -$3.44 $0.66 -$10.24 -$0.08 -$0.31
Period Ending 2020-11-30 2021-11-30 2022-11-30 2023-11-30 2024-11-30
Balance Sheet
Current Assets $21.1B $20.3B $19.5B $17.3B $17.5B
Total Assets $89.2B $96.5B $92.9B $97.8B $78.5B
Current Liabilities $30.4B $24.4B $28B $26.1B $27.5B
Total Liabilities $68.6B $65.9B $68.1B $70.1B $67.3B
Total Equity $20.6B $30.6B $24.7B $27.8B $11.3B
Total Debt $16.2B $13.8B $11.7B $9.3B $8.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-11-30 2023-11-30 2024-11-30 2023-11-30 2024-11-30
Cash Flow Statement
Cash Flow Operations $3.3B $1.5B $1.2B -$281M -$140M
Cash From Investing $2.8B -$4.9B $1.7B $85M -$76M
Cash From Financing -$6B -$102M -$2.4B $186M -$1.7B
Free Cash Flow $1.4B -$529M -- -$787M -$424M
WBA
Sector
Market Cap
$9.3B
$294.3M
Price % of 52-Week High
48.93%
73.07%
Dividend Yield
9.27%
0%
Shareholder Yield
14.13%
3.01%
1-Year Price Total Return
-50.91%
-12.61%
Beta (5-Year)
0.647
0.496
Dividend yield:
9.27%
Annualized payout:
$1.23
Payout ratio:
-12.01%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $10.03
200-day SMA
Sell
Level $11.26
Bollinger Bands (100)
Buy
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $10.52
Relative Strength Index (RSI14)
Buy
Level 51.22
ADX Line
Neutral
Level 0
Williams %R
Neutral
Level -35.5263
50-day SMA
Buy
Level $10.28
MACD (12, 26)
Sell
Level -0.10
25-day Aroon Oscillator
Sell
Level -64
On Balance Volume
Neutral
Level --

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.6081)
Sell
CA Score (Annual)
Level (-2.0171)
Buy
Beneish M-Score (Annual)
Level (-3.454)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.4585)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Stock Forecast FAQ

In the current month, WBA has received 3 Buy ratings 11 Hold ratings, and 2 Sell ratings. The WBA average analyst price target in the past 3 months is $12.35.

  • Where Will Walgreens Boots Alliance Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Walgreens Boots Alliance share price will rise to $12.35 per share over the next 12 months.

  • What Do Analysts Say About Walgreens Boots Alliance?

    Analysts are divided on their view about Walgreens Boots Alliance share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Walgreens Boots Alliance is a Sell and believe this share price will drop from its current level to $7.00.

  • What Is Walgreens Boots Alliance's Price Target?

    The price target for Walgreens Boots Alliance over the next 1-year time period is forecast to be $12.35 according to 16 Wall Street analysts, 3 of them rate the stock a Buy, 2 rate the stock a Sell, and 11 analysts rate the stock a Hold.

  • Is WBA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Walgreens Boots Alliance is a Hold. 11 of 16 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of WBA?

    You can purchase shares of Walgreens Boots Alliance via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Walgreens Boots Alliance shares.

  • What Is The Walgreens Boots Alliance Share Price Today?

    Walgreens Boots Alliance was last trading at $10.51 per share. This represents the most recent stock quote for Walgreens Boots Alliance. Yesterday, Walgreens Boots Alliance closed at $10.79 per share.

  • How To Buy Walgreens Boots Alliance Stock Online?

    In order to purchase Walgreens Boots Alliance stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is SoFi Worth?
What Is SoFi Worth?

Since SoFi’s CEO began snapping up shares of the student…

Is CVX a Buy, Sell or Hold?
Is CVX a Buy, Sell or Hold?

Energy giant Chevron Corporation (NYSE:CVX) has long been a pure-play…

What Will NVIDIA Stock Be Worth in 2030?
What Will NVIDIA Stock Be Worth in 2030?

NVIDIA (NASDAQ:NVDA) has been by far one of the best…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
17
CE alert for Feb 21

Celanese [CE] is down 4.21% over the past day.

Sell
22
GLBE alert for Feb 20

Global E Online [GLBE] is down 8.41% over the past day.

Buy
72
HIMS alert for Feb 20

Hims & Hers Health [HIMS] is down 3.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock